2021
DOI: 10.1186/s12859-021-04017-7
|View full text |Cite
|
Sign up to set email alerts
|

Common low complexity regions for SARS-CoV-2 and human proteomes as potential multidirectional risk factor in vaccine development

Abstract: Background The rapid spread of the COVID-19 demands immediate response from the scientific communities. Appropriate countermeasures mean thoughtful and educated choice of viral targets (epitopes). There are several articles that discuss such choices in the SARS-CoV-2 proteome, other focus on phylogenetic traits and history of the Coronaviridae genome/proteome. However none consider viral protein low complexity regions (LCRs). Recently we created the first methods that are able to compare such f… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
17
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 11 publications
(17 citation statements)
references
References 114 publications
0
17
0
Order By: Relevance
“…NSP3a can be classified as a “low complexity region,” found in many viruses, including Coronaviridae. Such regions are considered to be highly immunogenic and, importantly, they share high similarity with human epitopes, thus placing them a risk for antiviral drug or testing development ( Gruca et al, 2020 ). The enrichment of glutamic acid was found as a feature of the highly immunogenic polypeptides, in other organisms as well ( Hou et al, 2020 ).…”
Section: Discussionmentioning
confidence: 99%
“…NSP3a can be classified as a “low complexity region,” found in many viruses, including Coronaviridae. Such regions are considered to be highly immunogenic and, importantly, they share high similarity with human epitopes, thus placing them a risk for antiviral drug or testing development ( Gruca et al, 2020 ). The enrichment of glutamic acid was found as a feature of the highly immunogenic polypeptides, in other organisms as well ( Hou et al, 2020 ).…”
Section: Discussionmentioning
confidence: 99%
“…Given the immunological signi cance of pathogens' surface proteins in which many LCRs are located 6,7,9 , it is somewhat surprising that little attention has been given to their presence in viral proteomes. In sensu stricto, the presence and location of LCRs has only been reported in the HIV-1 8 and, more recently, in SARS-CoV-2 10 . They are rather abundant in the HIV-1 gp120 protein, and over 30% of them are located in the hypervariable regions of the connecting loops present in the protein, where they probably play a role in immune escape 8 .…”
Section: Introductionmentioning
confidence: 99%
“…They are rather abundant in the HIV-1 gp120 protein, and over 30% of them are located in the hypervariable regions of the connecting loops present in the protein, where they probably play a role in immune escape 8 . LCRs are scattered throughout the SARS-CoV-2 proteome, but are conspicuously absent in some proteins of the replication-transcription complex (RdRp, helicase, and NSP14 exonuclease), and in the NSP1, 3CL protease, NSP9-11, NSP15, ORF3a, membrane (M) protein, ORF6, ORF8 and ORF10 proteins 10 . This indicates that these proteins are under strong purifying selection, and that any compositional change is rapidly selected against.…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations